InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-25.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by West Linda, Director. Officer active across 1 company, notably Galera Therapeutics, Inc.. Cumulatively, 4 disclosures have been logged. Split: 4 buys · 0 sell. Total volume traded: €265k. History available since 28 May 2021. The latest transaction was filed on 17 December 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to West Linda
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
20,000 shares@ US$2.740218.2% of flowCommon StockSEC:0000899243-21-049012:0
Canonical exit: 17 Mar 2022 (T+90)
10,000 shares@ US$9.1328.4% of flowCommon StockSEC:0000899243-21-024505:0
Canonical exit: 13 Sept 2021 (T+90)
10,000 shares@ US$8.651126.7% of flowCommon StockSEC:0000899243-21-022167:0
Canonical exit: 31 Aug 2021 (T+90)
10,000 shares@ US$8.64126.7% of flowCommon StockSEC:0000899243-21-021576:0
Canonical exit: 26 Aug 2021 (T+90)
4 of 4 declarations
About West Linda
Linda West is a Director at Galera Therapeutics, Inc. In this role, she contributes to the governance of the company and strategic decision-making. Her experience in the biopharmaceutical sector allows her to make significant contributions to board discussions.
